SCHEMBL16493944

SCHEMBL16493944

CCN(CC)C(=O)Oc1cc(Cl)nnc1Cl

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 6/20 0.48
▸ TSHR P16473 1/20 0.48
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ RAB9A P51151 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.38
▸ MAOA P21397 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29053513 0.77 ALDH1A1 (0.41) LMNAKMT2ASMN1; SMN2KDM4EHSD17B10
SCHEMBL4442357 0.76 LMNA (0.47) LMNATSHRMEN1KMT2ASMN1; SMN2
SCHEMBL27579779 0.76 CFD (0.41) LMNATSHRKDM4EHSD17B10L3MBTL1
SCHEMBL5740998 0.74 TDP1 (0.39) LMNAKMT2AL3MBTL1RAB9AALDH1A1
SCHEMBL3656329 0.74 TDP1 (0.39) LMNAKMT2ASMN1; SMN2L3MBTL1RAB9A
SCHEMBL1189483 0.72 ALDH1A1 (0.44) LMNATSHRSMN1; SMN2L3MBTL1RAB9A
SCHEMBL2852976 0.72 LMNA (0.40) LMNATSHRMEN1KMT2ASMN1; SMN2
SCHEMBL2850664 0.72 LMNA (0.40) LMNATSHRMEN1KMT2ASMN1; SMN2
SCHEMBL29728538 0.71 LMNA (0.57) LMNATSHRMEN1KMT2ASMN1; SMN2
SCHEMBL16965114 0.71 LMNA (0.57) LMNATSHRMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2240486-B1 TRIAZOLIUM SALTS AS PAR1 INHIBITORS, THEIR MANUFACTURE AND THEIR APPLICATION AS MEDICINE SANOFI SA (FR) 2015-09-09 — — EP disclosed
EP-2240487-B1 TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS SANOFI SA (FR) 2011-12-14 — — EP disclosed
Send feedback